| Substance | Condition | Seq | Src | PMID | Dtl | Title |
| Fucoxanthin | Alzheimer's Disease | 7 | PM | 36978877 | 📋 | The Role of Fucoxanthin as a Potent Nrf2 Activator via Akt/GSK-3β/Fyn Axis against Amyloid-β Peptide-Induced Oxidative Damage |
| Fucoxanthin | Alzheimer's Disease | 6 | PM | 36435362 | 📋 | Multiple roles of fucoxanthin and astaxanthin against Alzheimer's disease: Their pharmacological potential and therapeutic insights |
| Fucoxanthin | Alzheimer's Disease | 5 | PM | 34792011 | 📋 | Neuroprotective Effect of Fucoxanthin against Intracerebroventricular Streptozotocin (ICV-STZ) Induced Cognitive Impairment in Experimental Rats |
| Fucoxanthin | Alzheimer's Disease | 3 | PM | 30639263 | 📋 | In Vitro Studies of the Neuroprotective Activities of Astaxanthin and Fucoxanthin Against Amyloid Beta (Aβ 1-42) Toxicity and Aggregation |
| Fucoxanthin | Alzheimer's Disease | 4 | PM | 28928905 | 📋 | Fucoxanthin, a Marine Carotenoid, Attenuates β-Amyloid Oligomer-Induced Neurotoxicity Possibly via Regulating the PI3K/Akt and the ERK Pathways in SH-SY5Y Cells |
| Fucoxanthin | Alzheimer's Disease | 1 | PM | 28478680 | 📋 | Fucoxanthin Inhibits β-Amyloid Assembly and Attenuates β-Amyloid Oligomer-Induced Cognitive Impairments |
| Fucoxanthin | Alzheimer's Disease | 2 | PM | 27023569 | 📋 | Fucoxanthin, a Marine Carotenoid, Reverses Scopolamine-Induced Cognitive Impairments in Mice and Inhibits Acetylcholinesterase in Vitro |
